The MarketReader Minute
💊 Insmed Soars on Strong Phase 2b PAH Data, Eyes FDA Engagement for Phase 3 | Biotech Sector Insights
(IBB) has seen a price increase of 0.5% since Monday. Ongoing US-China trade talks in London are fostering optimism, with expectations that reduced tensions may benefit global markets, including the biotechnology sector.